Lung Cancer in Never-smokers: a Case-control Study in a Radon-prone Area (Galicia, Spain)
Overview
Authors
Affiliations
The aim of the study was to assess the effect of residential radon exposure on the risk of lung cancer in never-smokers and to ascertain if environmental tobacco smoke modifies the effect of residential radon. We designed a multicentre hospital-based case-control study in a radon-prone area (Galicia, Spain). All participants were never-smokers. Cases had an anatomopathologically confirmed primary lung cancer and controls were recruited from individuals undergoing minor, non-oncological surgery. Residential radon was measured using alpha track detectors. We included 521 individuals, 192 cases and 329 controls, 21% were males. We observed an odds ratio of 2.42 (95% CI 1.45-4.06) for individuals exposed to ≥200 Bq·m(-3) compared with those exposed to <100 Bq·m(-3). Environmental tobacco smoke exposure at home increased lung cancer risk in individuals with radon exposure>200 Bq·m(-3). Individuals exposed to environmental tobacco smoke and to radon concentrations>200 Bq·m(-3) had higher lung cancer risk than those exposed to lower radon concentrations and exposed to environmental tobacco smoke. Residential radon increases lung cancer risk in never-smokers. An association between residential radon exposure and environmental tobacco smoke on the risk of lung cancer might exist.
Mphaga K, Utembe W, Mbonane T, Rathebe P Heliyon. 2024; 10(23):e40439.
PMID: 39654791 PMC: 11625298. DOI: 10.1016/j.heliyon.2024.e40439.
Assessment of exposure to secondhand tobacco smoke in Spain: A scoping review.
Blanco-Ferreiro A, Teijeiro A, Varela-Lema L, Rey-Brandariz J, Candal-Pedreira C, Martin-Gisbert L Tob Induc Dis. 2024; 22.
PMID: 39398343 PMC: 11468508. DOI: 10.18332/tid/192118.
Mphaga K, Utembe W, Rathebe P Front Public Health. 2024; 12:1328955.
PMID: 38525346 PMC: 10957527. DOI: 10.3389/fpubh.2024.1328955.
Social determinants of health and lung cancer surgery: a qualitative study.
Teteh D, Ferrell B, Okunowo O, Downie A, Erhunmwunsee L, Montgomery S Front Public Health. 2023; 11:1285419.
PMID: 38026333 PMC: 10644827. DOI: 10.3389/fpubh.2023.1285419.
Ruano-Ravina A, Martin-Gisbert L, Kelsey K, Perez-Rios M, Candal-Pedreira C, Rey-Brandariz J Clin Transl Oncol. 2023; 25(12):3357-3368.
PMID: 37610496 PMC: 10603006. DOI: 10.1007/s12094-023-03308-0.